- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting the relaxin hormonal pathway in prostate cancer
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF CANCER
Volume 137, Issue 10, Pages 2287-2295
Publisher
Wiley
Online
2014-07-16
DOI
10.1002/ijc.29079
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Relaxin receptor antagonist AT-001 synergizes with docetaxel in androgen-independent prostate xenografts
- (2014) Anton Neschadim et al. ENDOCRINE-RELATED CANCER
- Phase II clinical trial of cediranib in patients with metastatic castration-resistant prostate cancer
- (2013) William L. Dahut et al. BJU INTERNATIONAL
- Role of relaxin-2 in human primary osteosarcoma
- (2013) Jinfeng Ma et al. Cancer Cell International
- Glucocorticoid Receptor Confers Resistance to Antiandrogens by Bypassing Androgen Receptor Blockade
- (2013) Vivek K. Arora et al. CELL
- Relaxins enhance growth of spontaneous murine breast cancers as well as metastatic colonization of the brain
- (2013) Claudia Binder et al. CLINICAL & EXPERIMENTAL METASTASIS
- Amplitude modulation of androgen signaling by c-MYC
- (2013) M. Ni et al. GENES & DEVELOPMENT
- Sunitinib Plus Androgen Deprivation and Radiation Therapy for Patients With Localized High-Risk Prostate Cancer: Results From a Multi-institutional Phase 1 Study
- (2013) Paul G. Corn et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Abiraterone acetate plus prednisone versus prednisone alone in chemotherapy-naive men with metastatic castration-resistant prostate cancer: patient-reported outcome results of a randomised phase 3 trial
- (2013) Ethan Basch et al. LANCET ONCOLOGY
- Androgen receptor functions in castration-resistant prostate cancer and mechanisms of resistance to new agents targeting the androgen axis
- (2013) X Yuan et al. ONCOGENE
- Serum Relaxin Levels in Young Athletic Men Are Comparable With Those in Women
- (2013) Jennifer Moriatis Wolf et al. ORTHOPEDICS
- Relaxin Family Peptides and Their Receptors
- (2013) R. A. D. Bathgate et al. PHYSIOLOGICAL REVIEWS
- Elevated serum levels of human relaxin-2 in patients with esophageal squamous cell carcinoma
- (2013) Peng Ren WORLD JOURNAL OF GASTROENTEROLOGY
- Identification and optimization of small-molecule agonists of the human relaxin hormone receptor RXFP1
- (2013) Jingbo Xiao et al. Nature Communications
- An F876L Mutation in Androgen Receptor Confers Genetic and Phenotypic Resistance to MDV3100 (Enzalutamide)
- (2013) M. Korpal et al. Cancer Discovery
- Effect of treatment with 5-α reductase inhibitors on progression in monitored men with favourable-risk prostate cancer
- (2012) Ashley E. Ross et al. BJU INTERNATIONAL
- Clinical development of novel therapeutics for castration-resistant prostate cancer
- (2012) Matthew D. Galsky et al. CA-A CANCER JOURNAL FOR CLINICIANS
- ARN-509: A Novel Antiandrogen for Prostate Cancer Treatment
- (2012) N. J. Clegg et al. CANCER RESEARCH
- Androgen hormone action in prostatic carcinogenesis: stromal androgen receptors mediate prostate cancer progression, malignant transformation and metastasis
- (2012) Emily A. Ricke et al. CARCINOGENESIS
- Castration-resistant metastatic prostate cancer: current status and treatment possibilities
- (2012) Joan Carles et al. Clinical & Translational Oncology
- Efficacy of Cetuximab in Metastatic Castration-Resistant Prostate Cancer Might Depend on EGFR and PTEN Expression: Results from a Phase II Trial (SAKK 08/07)
- (2012) R. Cathomas et al. CLINICAL CANCER RESEARCH
- Subtleties in GPCR drug discovery: a medicinal chemistry perspective
- (2012) Masahiko Fujioka et al. DRUG DISCOVERY TODAY
- Recombinant H2 relaxin inhibits apoptosis and induces cell proliferation in cultured leiomyoma cells without affecting those in cultured normal myometrial cells
- (2012) Kaho Suzuki et al. FERTILITY AND STERILITY
- Gonadotropin-releasing hormone: An update review of the antagonists versus agonists
- (2012) Hein Van Poppel et al. INTERNATIONAL JOURNAL OF UROLOGY
- Effect of Relaxin on Human Sperm Functions
- (2012) A. Ferlin et al. JOURNAL OF ANDROLOGY
- Cabozantinib in Patients With Advanced Prostate Cancer: Results of a Phase II Randomized Discontinuation Trial
- (2012) David C. Smith et al. JOURNAL OF CLINICAL ONCOLOGY
- Wnt/β-catenin signalling in prostate cancer
- (2012) Robert M. Kypta et al. Nature Reviews Urology
- Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
- (2012) Howard I. Scher et al. NEW ENGLAND JOURNAL OF MEDICINE
- New considerations for ADT in advanced prostate cancer and the emerging role of GnRH antagonists
- (2012) N D Shore et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Prospective Correlation Between Serum Relaxin Concentration and Anterior Cruciate Ligament Tears Among Elite Collegiate Female Athletes
- (2011) Jason L. Dragoo et al. AMERICAN JOURNAL OF SPORTS MEDICINE
- Upregulated FGFR1 expression is associated with the transition of hormone-naive to castrate-resistant prostate cancer
- (2011) K Armstrong et al. BRITISH JOURNAL OF CANCER
- Molecular Alterations during Progression of Prostate Cancer to Androgen Independence
- (2011) P. Saraon et al. CLINICAL CHEMISTRY
- Androgen Deprivation Therapy as Primary Treatment for Prostate Cancer
- (2011) Dara H. Cannata et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Old issues and new perspectives on prostate cancer hormonal therapy: the molecular substratum
- (2011) Leonardo Oliveira Reis MEDICAL ONCOLOGY
- Relaxin Enhances the Collagenolytic Activity and In Vitro Invasiveness by Upregulating Matrix Metalloproteinases in Human Thyroid Carcinoma Cells
- (2011) J. Bialek et al. MOLECULAR CANCER RESEARCH
- Abiraterone and Increased Survival in Metastatic Prostate Cancer
- (2011) Johann S. de Bono et al. NEW ENGLAND JOURNAL OF MEDICINE
- The role of androgens in follicle maturation and ovulation induction: friend or foe of infertility treatment?
- (2011) Norbert Gleicher et al. Reproductive Biology and Endocrinology
- Complete androgen blockade safely allows for delay of cytotoxic chemotherapy in castration refractory prostate cancer
- (2011) Rafael A. Kaliks et al. International Braz J Urol
- Dual Blockade of PKA and NF–κB Inhibits H2 Relaxin-Mediated Castrate-Resistant Growth of Prostate Cancer Sublines and Induces Apoptosis
- (2011) Ruth L. Vinall et al. Hormones & Cancer
- Suppression of relaxin receptor RXFP1 decreases prostate cancer growth and metastasis
- (2010) Shu Feng et al. ENDOCRINE-RELATED CANCER
- Influence of Sex Hormones on Cancer Progression
- (2010) Elizabeth J. Folkerd et al. JOURNAL OF CLINICAL ONCOLOGY
- Relaxin Enhances S100A4 and Promotes Growth of Human Thyroid Carcinoma Cell Xenografts
- (2010) Y. Radestock et al. MOLECULAR CANCER RESEARCH
- Relaxin family peptides in the male reproductive system--a critical appraisal
- (2010) R. Ivell et al. MOLECULAR HUMAN REPRODUCTION
- Effect of Dutasteride on the Risk of Prostate Cancer
- (2010) Gerald L. Andriole et al. NEW ENGLAND JOURNAL OF MEDICINE
- Relaxin drives Wnt signaling through upregulation of PCDHY in prostate cancer
- (2010) Vanessa C. Thompson et al. PROSTATE
- The chemically synthesized human relaxin-2 analog, B-R13/17K H2, is an RXFP1 antagonist
- (2009) Mohammed Akhter Hossain et al. AMINO ACIDS
- Sex Steroids Upregulate the IGF-1R in Prostate Cancer Cells through a Nongenotropic Pathway
- (2009) Giuseppe Pandini et al. Annals of the New York Academy of Sciences
- Relaxin/RXFP1 Signaling in Prostate Cancer Progression
- (2009) Shu Feng et al. Annals of the New York Academy of Sciences
- Abarelix and other gonadotrophin-releasing hormone antagonists in prostate cancer
- (2009) Roger S. Kirby et al. BJU INTERNATIONAL
- Epidermal growth factor receptor expression escapes androgen regulation in prostate cancer: a potential molecular switch for tumour growth
- (2009) A M Traish et al. BRITISH JOURNAL OF CANCER
- Treatment-Dependent Androgen Receptor Mutations in Prostate Cancer Exploit Multiple Mechanisms to Evade Therapy
- (2009) M. P. Steinkamp et al. CANCER RESEARCH
- Androgen Receptor Roles in Spermatogenesis and Fertility: Lessons from Testicular Cell-Specific Androgen Receptor Knockout Mice
- (2009) Ruey-Sheng Wang et al. ENDOCRINE REVIEWS
- Selective Inhibition of CYP17 With Abiraterone Acetate Is Highly Active in the Treatment of Castration-Resistant Prostate Cancer
- (2009) Gerhardt Attard et al. JOURNAL OF CLINICAL ONCOLOGY
- Investigation of the Local Expression of the Relaxin System in Canine Mammary Tumours
- (2009) O Lamp et al. REPRODUCTION IN DOMESTIC ANIMALS
- Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer
- (2009) C. Tran et al. SCIENCE
- The efficacy and safety of degarelix: a 12-month, comparative, randomized, open-label, parallel-group phase III study in patients with prostate cancer
- (2008) Laurence Klotz et al. BJU INTERNATIONAL
- Androgen Receptor and Invasion in Prostate Cancer
- (2008) T. Hara et al. CANCER RESEARCH
- Relaxin family peptide receptors – from orphans to therapeutic targets
- (2008) Emma T. van der Westhuizen et al. DRUG DISCOVERY TODAY
- International epidemiology of prostate cancer: Geographical distribution and secular trends
- (2008) Peter D. Baade et al. MOLECULAR NUTRITION & FOOD RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now